These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 2168107)

  • 1. The effect of peptides containing the arginine-glycine-aspartic acid sequence on the adsorption of foot-and-mouth disease virus to tissue culture cells.
    Baxt B; Becker Y
    Virus Genes; 1990 Jun; 4(1):73-83. PubMed ID: 2168107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cell attachment site on foot-and-mouth disease virus includes the amino acid sequence RGD (arginine-glycine-aspartic acid).
    Fox G; Parry NR; Barnett PV; McGinn B; Rowlands DJ; Brown F
    J Gen Virol; 1989 Mar; 70 ( Pt 3)():625-37. PubMed ID: 2543752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Is the Arg-Gly-Asp sequence the site for foot-and-mouth disease virus binding with cell receptor?].
    Surovoĭ AIu; Ivanov VT; Chepurkin AV; Ivaniushchenkov VN; Driagalin NN
    Bioorg Khim; 1988 Jul; 14(7):965-8. PubMed ID: 2847760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RGD-containing peptides of VP1 of foot-and-mouth disease virus (FMDV) prevent virus infection in vitro.
    Liebermann H; Dölling R; Schmidt D; Thalmann G
    Acta Virol; 1991 Jan; 35(1):90-3. PubMed ID: 1683122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arginine-glycine-aspartic acid-specific binding by foot-and-mouth disease viruses to the purified integrin alpha(v)beta3 in vitro.
    Jackson T; Sharma A; Ghazaleh RA; Blakemore WE; Ellard FM; Simmons DL; Newman JW; Stuart DI; King AM
    J Virol; 1997 Nov; 71(11):8357-61. PubMed ID: 9343190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell recognition by foot-and-mouth disease virus that lacks the RGD integrin-binding motif: flexibility in aphthovirus receptor usage.
    Baranowski E; Ruiz-Jarabo CM; Sevilla N; Andreu D; Beck E; Domingo E
    J Virol; 2000 Feb; 74(4):1641-7. PubMed ID: 10644333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A recombinant, arginine-glycine-aspartic acid (RGD) motif from foot-and-mouth disease virus binds mammalian cells through vitronectin and, to a lower extent, fibronectin receptors.
    Villaverde A; Feliu JX; Harbottle RP; Benito A; Coutelle C
    Gene; 1996 Nov; 180(1-2):101-6. PubMed ID: 8973352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Foot-and-mouth disease virus can utilize the C-terminal extension of coxsackievirus A9 VP1 for cell infection.
    Leippert M; Pfaff E
    J Gen Virol; 2001 Jul; 82(Pt 7):1703-1711. PubMed ID: 11413382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategy for producing new foot-and-mouth disease vaccines that display complex epitopes.
    McKenna TS; Rieder E; Lubroth J; Burrage T; Baxt B; Mason PW
    J Biotechnol; 1996 Jan; 44(1-3):83-9. PubMed ID: 8717390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Animal-derived antigenic variants of foot-and-mouth disease virus type A12 have low affinity for cells in culture.
    Rieder E; Baxt B; Mason PW
    J Virol; 1994 Aug; 68(8):5296-9. PubMed ID: 8035529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Foot-and-mouth disease virus is a ligand for the high-affinity binding conformation of integrin alpha5beta1: influence of the leucine residue within the RGDL motif on selectivity of integrin binding.
    Jackson T; Blakemore W; Newman JW; Knowles NJ; Mould AP; Humphries MJ; King AM
    J Gen Virol; 2000 May; 81(Pt 5):1383-91. PubMed ID: 10769082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Propagation of an attenuated virus by design: engineering a novel receptor for a noninfectious foot-and-mouth disease virus.
    Rieder E; Berinstein A; Baxt B; Kang A; Mason PW
    Proc Natl Acad Sci U S A; 1996 Sep; 93(19):10428-33. PubMed ID: 8816817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of substituted and tandem-repeated peptides to probe the relevance of the highly conserved RGD tripeptide in the immune response against foot-and-mouth disease virus.
    Novella IS; Borrego B; Mateu MG; Domingo E; Giralt E; Andreu D
    FEBS Lett; 1993 Sep; 330(3):253-9. PubMed ID: 7690714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic peptides mimic subtype specificity of foot-and-mouth disease virus.
    Clarke BE; Carroll AR; Rowlands DJ; Nicholson BH; Houghten RA; Lerner RA; Brown F
    FEBS Lett; 1983 Jul; 157(2):261-4. PubMed ID: 6190676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of T-cell reactivity to synthetic peptide analogues of foot-and-mouth disease virus in sheep by amino acid substitutions.
    Flynn JN; Harkiss GD; Moore D; DiMarchi R
    Vet Immunol Immunopathol; 1992 Mar; 31(3-4):255-66. PubMed ID: 1375405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RGD sequence of foot-and-mouth disease virus is essential for infecting cells via the natural receptor but can be bypassed by an antibody-dependent enhancement pathway.
    Mason PW; Rieder E; Baxt B
    Proc Natl Acad Sci U S A; 1994 Mar; 91(5):1932-6. PubMed ID: 8127909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Point mutations within the betaG-betaH loop of foot-and-mouth disease virus O1K affect virus attachment to target cells.
    Leippert M; Beck E; Weiland F; Pfaff E
    J Virol; 1997 Feb; 71(2):1046-51. PubMed ID: 8995624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cell adhesion peptide from foot-and-mouth disease virus can direct cell targeted delivery of a functional enzyme.
    Villaverde A; Feliu JX; Arís A; Harbottle RP; Benito A; Coutelle C
    Biotechnol Bioeng; 1998 Aug; 59(3):294-301. PubMed ID: 10099340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A single amino acid substitution affects multiple overlapping epitopes in the major antigenic site of foot-and-mouth disease virus of serotype C.
    Mateu MG; Martínez MA; Capucci L; Andreu D; Giralt E; Sobrino F; Brocchi E; Domingo E
    J Gen Virol; 1990 Mar; 71 ( Pt 3)():629-37. PubMed ID: 1690261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delineation of a neutralizing subregion within the immunodominant epitope (GH loop) of foot-and-mouth disease virus VP1 which does not contain the RGD motif.
    Brown F; Benkirane N; Limal D; Halimi H; Newman JF; Van Regenmortel MH; Briand JP; Muller S
    Vaccine; 1999 Aug; 18(1-2):50-6. PubMed ID: 10501234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.